168 related articles for article (PubMed ID: 27488427)
1. 68Ga-PSMA PET/MR Showing Intense PSMA Uptake in Nodular Fasciitis Mimicking Prostate Cancer Metastasis.
Henninger M; Maurer T; Hacker C; Eiber M
Clin Nucl Med; 2016 Oct; 41(10):e443-4. PubMed ID: 27488427
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-Prostate-Specific Membrane Antigen-Avid Tubercular Lesions Mimicking Prostate Cancer Metastasis on Simultaneous Prostate-Specific Membrane Antigen PET/MRI.
Ahuja A; Taneja S; Thorat K; Jena A
Clin Nucl Med; 2017 Dec; 42(12):e509-e510. PubMed ID: 29036003
[TBL] [Abstract][Full Text] [Related]
3. Intense PSMA-expression using (68)Ga-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis.
Rischpler C; Maurer T; Schwaiger M; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):193-194. PubMed ID: 26502982
[No Abstract] [Full Text] [Related]
4. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C
Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
[TBL] [Abstract][Full Text] [Related]
6. Utility of
Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
[TBL] [Abstract][Full Text] [Related]
7. Paget Disease: A Potential Pitfall in PSMA PET for Prostate Cancer.
Blazak JK; Thomas P
Clin Nucl Med; 2016 Sep; 41(9):699-700. PubMed ID: 27405026
[TBL] [Abstract][Full Text] [Related]
8. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.
Hofman MS; Iravani A
PET Clin; 2017 Apr; 12(2):219-234. PubMed ID: 28267455
[TBL] [Abstract][Full Text] [Related]
9. Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT.
Soydal C; Ozkan E; Yerlikaya H; Utkan G; Kucuk ON
Clin Nucl Med; 2016 Jun; 41(6):e294-5. PubMed ID: 26909710
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Bilateral Testicular Metastases From Prostatic Adenocarcinoma Using 68Ga-PSMA Ligand PET/CT.
Weiberg D; Radner H; Derlin T; Thon WF
Clin Nucl Med; 2017 Jul; 42(7):563-564. PubMed ID: 28368893
[TBL] [Abstract][Full Text] [Related]
11. Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT.
Demirci E; Has Simsek D; Kabasakal L; Mülazimoğlu M
Clin Nucl Med; 2017 Dec; 42(12):e504-e505. PubMed ID: 29076911
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
Hofman MS; Hicks RJ; Maurer T; Eiber M
Radiographics; 2018; 38(1):200-217. PubMed ID: 29320333
[TBL] [Abstract][Full Text] [Related]
13. Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis.
Plouznikoff N; Artigas C; Karfis I; Flamen P
Clin Nucl Med; 2020 Jan; 45(1):e41-e42. PubMed ID: 31246686
[TBL] [Abstract][Full Text] [Related]
14. Image of the Month: Multifocal 68Ga Prostate-Specific Membrane Antigen Ligand Uptake in the Skeleton in a Man With Both Prostate Cancer and Multiple Myeloma.
Rauscher I; Maurer T; Steiger K; Schwaiger M; Eiber M
Clin Nucl Med; 2017 Jul; 42(7):547-548. PubMed ID: 28368889
[TBL] [Abstract][Full Text] [Related]
15. Comparison of bone scintigraphy and
Pyka T; Okamoto S; Dahlbender M; Tauber R; Retz M; Heck M; Tamaki N; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2114-2121. PubMed ID: 27290607
[TBL] [Abstract][Full Text] [Related]
16. The
Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
18. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.
Afshar-Oromieh A; Haberkorn U; Eder M; Eisenhut M; Zechmann CM
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1085-6. PubMed ID: 22310854
[No Abstract] [Full Text] [Related]
19. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer.
Aragon-Ching JB
Asian J Androl; 2021; 23(1):1-2. PubMed ID: 32719192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
